Literature DB >> 9596744

Effects of toxin A from Clostridium difficile on mast cell activation and survival.

G M Calderón1, J Torres-López, T J Lin, B Chavez, M Hernández, O Muñoz, A D Befus, J A Enciso.   

Abstract

Toxins A and B from Clostridium difficile are the main cause of antibiotic-associated diarrhea and pseudomembranous colitis. They cause fluid accumulation, necrosis, and a strong inflammatory response when inoculated in intestinal loops. Since mast cells are a rich source of inflammatory mediators, abundant in the gut, and known to be involved in C. difficile-induced enteritis, we studied the in vitro effect of toxin A on isolated mast cells. Normal rats sensitized by infection with Nippostrongilus brasiliensis were used to isolate peritoneal mast cells (PMC). PMC from naive rats were stimulated with calcium ionophore A23187 as a model of antigen-independent activation, and PMC from sensitized rats were stimulated with N. brasiliensis antigens to study immunoglobulin E-dependent mast cell activation. After 4 h, toxin A did not induce release of nitric oxide or histamine in naive PMC. However, 10 ng of toxin per ml caused a significant release of tumor necrosis factor alpha (TNF-alpha). In contrast, 1 microg of toxin per ml inhibited antigen or A23187-induced histamine release by PMC. Toxin A at 1 microg/ml for 4 h caused disruption of actin which aggregated in the cytoplasm and around the nucleus. After 24 h, chromatin condensation, cytoplasmic blebbing, and apoptotic-like vesicles were observed; DNA fragmentation was documented also. These results suggest that mast cells may participate in the initial inflammatory response to C. difficile infection by releasing TNF-alpha upon interaction with toxin A. However, longer exposure to toxin A affects the release of inflammatory mediators, perhaps because of the alteration of the cytoskeleton and induction of apoptosis. The impaired functions and survival of mast cells by C. difficile toxin A could hamper the capacity of these cells to counteract the infection, thus prolonging the pathogenic effects of C. difficile toxins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596744      PMCID: PMC108266          DOI: 10.1128/IAI.66.6.2755-2761.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Macrophage-dependent stimulation of T cell-depleted spleen cells by Clostridium difficile toxin A and calcium ionophore.

Authors:  P D Miller; C Pothoulakis; T R Baeker; J T LaMont; T L Rothstein
Journal:  Cell Immunol       Date:  1990-03       Impact factor: 4.868

Review 2.  Clostridium difficile toxin A and its effects on cells.

Authors:  C Fiorentini; M Thelestam
Journal:  Toxicon       Date:  1991       Impact factor: 3.033

3.  Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine.

Authors:  J Torres; E Jennische; S Lange; I Lönnroth
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

4.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

5.  Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine.

Authors:  I Kurose; C Pothoulakis; J T LaMont; D C Anderson; J C Paulson; M Miyasaka; R Wolf; D N Granger
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin.

Authors:  M Giry; M R Popoff; C von Eichel-Streiber; P Boquet
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Analysis of human skin mast cell proteins by two-dimensional gel electrophoresis. Identification of tryptase as a sialylated glycoprotein.

Authors:  R C Benyon; J A Enciso; A D Befus
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

8.  Characteristics of histamine secretion from rat peritoneal mast cells sensitized to the nematode Nippostrongylus brasiliensis.

Authors:  J R White; F L Pearce
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

9.  The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins.

Authors:  I Just; M Wilm; J Selzer; G Rex; C von Eichel-Streiber; M Mann; K Aktories
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

10.  Clostridium difficile toxins A and B inhibit human immune response in vitro.

Authors:  W Däubener; E Leiser; C von Eichel-Streiber; U Hadding
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

View more
  10 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis.

Authors:  I C Cavalcante; M V Castro; A R F Barreto; G W Sullivan; M Vale; P R C Almeida; J Linden; J M Rieger; F Q Cunha; R L Guerrant; R A Ribeiro; G A C Brito
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

4.  Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro.

Authors:  Benedito A Carneiro; Jun Fujii; Gerly A C Brito; Cirle Alcantara; Reinaldo B Oriá; Aldo A M Lima; Tom Obrig; Richard L Guerrant
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Down-regulation of interleukin-16 in human mast cells HMC-1 by Clostridium difficile toxins A and B.

Authors:  Ralf Gerhard; Swenja Queisser; Helma Tatge; Gesa Meyer; Oliver Dittrich-Breiholz; Michael Kracht; Hanping Feng; Ingo Just
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-26       Impact factor: 3.000

Review 6.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

Review 7.  Human umbilical cord blood-derived mast cells: a unique model for the study of neuro-immuno-endocrine interactions.

Authors:  T C Theoharides; D Kempuraj; M Tagen; M Vasiadi; C L Cetrulo
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

8.  Clostridium difficile toxins A and B directly stimulate human mast cells.

Authors:  Gesa K A Meyer; Anne Neetz; Gudrun Brandes; Dimitrios Tsikas; Joseph H Butterfield; Ingo Just; Ralf Gerhard
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

Review 9.  The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.

Authors:  Xingmin Sun; Simon A Hirota
Journal:  Mol Immunol       Date:  2014-09-18       Impact factor: 4.407

10.  High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.

Authors:  Kevin M D'Auria; Meghan J Bloom; Yesenia Reyes; Mary C Gray; Edward J van Opstal; Jason A Papin; Erik L Hewlett
Journal:  BMC Microbiol       Date:  2015-02-04       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.